Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study

Imagem de Miniatura
Arquivos
art_LOPES_Rationale_and_design_of_the_First_Brazilian_Cardiovascular_2016.PDF (303.7 KB)
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MOSBY-ELSEVIER
Autores
LOPES, Renato D.
PAOLA, Angelo Amato Vicenzo de
LORGA FILHO, Adalberto Menezes
ANDRADE, Jadelson
MATTOS, Luiz Alberto Piva e
BERNARDEZ-PEREIRA, Sabrina
BERWANGER, Otavio
FIGUEIREDO, Marcio Jansen de Oliveira
Citação
AMERICAN HEART JOURNAL, v.176, p.10-16, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Atrial fibrillation (AF) is an important and growing public health problem worldwide, but data about its actual prevalence, therapeutic management, and clinical outcomes in middle-to low-income countries are scarce. Design The First Brazilian Cardiovascular Registry of Atrial Fibrillation (the RECALL study) will assess demographic characteristics and evidence-based practice of a representative sample of patients with AF in Brazil. The prospective, multicenter registry has a planned sample size of around 5,000 patients at approximately 80 sites. Eligibility criteria include age > 18 years and permanent, paroxysmal, or persistent AF documented by electrocardiogram, 24-hour Holter monitoring, or device interrogation. Patients will be followed up through 1 year after enrollment. Information on laboratory tests, echocardiographic data, medication use, and clinical outcomes will be obtained. Various aspects of the population will be described, including demographic characteristics; antithrombotic therapies; antiarrhythmic agents; level of control of international normalized ratio (by average time within the therapeutic range) among patients using vitamin K antagonists; rates of warfarin discontinuation; outcomes such as death, stroke, systemic embolism, and major bleeding within 1 year after enrollment in the study; and rates of electrical cardioversion, percutaneous ablation of AF, ablation of the atrioventricular junction, and pacemaker/cardioverter-defibrillator implantation. Summary RECALL is the first prospective, multicenter registry of AF in Brazil. This study will provide important information about demographics, practice patterns, treatments, and associated outcomes in patients with AF. The results of this registry will also allow Brazilian data to be put in perspective with other AF registries across the world and provide opportunities to improve care of patients with AF in Brazil.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/14532
Referências
  1. Lin HJ, 1996, STROKE, V27, P1760
  2. Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119
  3. Goto S, 2008, AM HEART J, V156, P855, DOI 10.1016/j.ahj.2008.06.029
  4. Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONHA.106.653048
  5. Kirchhof P, 2014, EUROPACE, V16, P6, DOI 10.1093/europace/eut263
  6. Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
  7. Hart RG, 2007, ANN INTERN MED, V146, P857
  8. Le Heuzey JY, 2010, AM J CARDIOL, V105, P687, DOI 10.1016/j.amjcard.2009.10.012
  9. WOLF PA, 1991, STROKE, V22, P312
  10. [Anonymous], 1995, ARCH INTERN MED, DOI 10.1001/ARCHINTE.1995.00430050045005
  11. Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292
  12. Garwood CL, 2008, ANN PHARMACOTHER, V42, P523, DOI 10.1345/aph.1K498
  13. Benjamin EJ, 1998, CIRCULATION, V98, P946
  14. Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488
  15. Wattigney WA, 2003, CIRCULATION, V108, P711, DOI 10.1161/01.CIR.0000083722.42033.0A
  16. Huisman MV, 2014, AM HEART J, V167, P329, DOI 10.1016/j.ahj.2013.12.006
  17. Steg PG, 2012, HEART, V98, P195, DOI 10.1136/heartjnl-2011-300550
  18. Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505
  19. Piccini JP, 2011, AM HEART J, V162, P606, DOI 10.1016/j.ahj.2011.07.001
  20. Zimerman LI, 2009, ARQ BRAS CARDIOL, V92, P1
  21. Banerjee A, 2012, THROMB HAEMOSTASIS, V107, P584, DOI 10.1160/TH11-11-0784
  22. Chan PS, 2011, AM J CARDIOL, V108, P1136, DOI 10.1016/j.amjcard.2011.06.017
  23. Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011
  24. Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253
  25. Dulli DA, 2003, NEUROEPIDEMIOLOGY, V22, P118, DOI 10.1159/000068743
  26. Go AS, 1999, ANN INTERN MED, V131, P927
  27. Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185
  28. WOLF PA, 1991, STROKE, V22, P983
  29. Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
  30. Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93
  31. Nabauer M, 2009, EUROPACE, V11, P423, DOI 10.1093/europace/eun369
  32. Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025
  33. Chow SC, 2008, SAMPLE SIZE CALCULAT
  34. January CT, 2014, CIRCULATION, V130, pE199, DOI 10.1161/CIR.0000000000000041
  35. Lwanga SK, 1991, SAMPLE SIZE DETERMIN
  36. Olesen JB, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d124
  37. Ruff CT, 2013, LANCET, V383, P955
  38. SOCIEDADE BRASILEIRA DE CARDIOLOGIA, 2013, ARQ BRAS CARDIOL, V101, P1
  39. Zoni-Berisso Massimo, 2014, Clin Epidemiol, V6, P213, DOI 10.2147/CLEP.S47385

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - ODS/03